Kazia Therapeutics (KZIA) Asset Writedowns and Impairment (2009)
Kazia Therapeutics' Asset Writedowns and Impairment came in at $8.57 million for the year ended Jun 30, 2025.
Powered by 
Analysis
Kazia Therapeutics (KZIA) Asset Writedowns and Impairment (2009) Analysis & Trends
Going back to the year ended Dec 31, 2009, Kazia Therapeutics' Asset Writedowns and Impairment data covers 7 years.
- The figure for the year ended Jun 30, 2025 represents the highest annual Asset Writedowns and Impairment in data going back to the year ended Dec 31, 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Kazia Therapeutics | 68.33 Mn | 68.33 Mn | - |
API Access
Kazia Therapeutics Asset Writedowns and Impairment API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=KZIA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-writedowns-and-impairment", "ticker": "KZIA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=KZIA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();